Lovaltech welcomes a new team member

With a PhD in Immuno-Oncology, Mélanie Rose is a specialist in immunology and translational research. She has developed a strong background combining R&D and innovation strategy.
As Director of Innovation at Lovaltech, she bridges scientific research and strategic decision-making, guiding preclinical and clinical programs toward partnerships and scientific value.

We are especially pleased to welcome Mélanie to our team at a key moment for the company, as we approach the launch of the Phase II clinical trials of our first nasal vaccine.